Medmix Group Overview
- Year Founded
-
1922
- Status
-
Public
- Employees
-
2,587
- Stock Symbol
-
MEDX
- Investments
-
4
- Share Price
-
$12.47
- (As of Thursday Closing)
Medmix Group General Information
Description
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
Contact Information
Website
www.medmix.swissCorporate Office
- Neuhofstrasse 20
- 6340 Baar
- Switzerland
Corporate Office
- Neuhofstrasse 20
- 6340 Baar
- Switzerland
Medmix Group Stock Performance
As of 12-Nov-2026, Medmix Group’s stock price is $12.47. Its current market cap is $520M with 41.7M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.47 | $12.65 | $9.35 - $15.89 | $520M | 41.7M | 65.3K |
Medmix Group Financials Summary
As of 30-Jun-2026, Medmix Group has a trailing 12-month revenue of $551M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 703,351 | 858,354 | 656,165 | 1,114,958 |
| Revenue | 550,641 | 539,038 | 549,568 | 541,316 |
| EBITDA | 88,833 | 88,797 | 75,184 | 77,871 |
| Net Income | 126 | 7,701 | (8,404) | 334 |
| Total Assets | 1,201,307 | 1,207,698 | 1,056,080 | 1,198,657 |
| Total Debt | 395,361 | 417,088 | 357,929 | 416,339 |
Medmix Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medmix Group Patents
Medmix Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018077575-A1 | Modular discharge device with separator element | Inactive | 24-Oct-2016 | ||
| WO-2018010914-A1 | Mixing and delivery system for bone replacement material | Inactive | 12-Jul-2016 | ||
| WO-2017092884-A1 | Mixing and application system for a dental preparation | Inactive | 30-Nov-2015 | ||
| WO-2017076634-A2 | Dispensing device with lateral inlet port and advancement mechanism | Inactive | 06-Nov-2015 | ||
| WO-2017076634-A3 | Dispensing device with lateral inlet port and advancement mechanism | Inactive | 06-Nov-2015 | A61B17/00491 |
Medmix Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Medmix Group Investments & Acquisitions (4)
Medmix Group’s most recent deal was a Secondary Transaction - Private with Qiaoyi Plastic. The deal was made on 01-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Qiaoyi Plastic | 01-Jan-2024 | Secondary Transaction - Private | Personal Products | ||
| AARDEX Group | 10-Nov-2023 | Corporate | Other Healthcare Technology Systems | ||
| Qiaoyi Plastic | 06-Jul-2023 | Merger/Acquisition | Personal Products | ||
| Universal (Plastics business) | 24-Oct-2022 | Merger/Acquisition | Other Commercial Products |
Medmix Group ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
22.48 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Medmix Group FAQs
-
When was Medmix Group founded?
Medmix Group was founded in 1922.
-
Where is Medmix Group headquartered?
Medmix Group is headquartered in Baar, Switzerland.
-
What is the size of Medmix Group?
Medmix Group has 2,587 total employees.
-
What industry is Medmix Group in?
Medmix Group’s primary industry is Surgical Devices.
-
Is Medmix Group a private or public company?
Medmix Group is a Public company.
-
What is Medmix Group’s stock symbol?
The ticker symbol for Medmix Group is MEDX.
-
What is the current stock price of Medmix Group?
As of 12-Nov-2026 the stock price of Medmix Group is $12.47.
-
What is the current market cap of Medmix Group?
The current market capitalization of Medmix Group is $520M.
-
What is Medmix Group’s current revenue?
The trailing twelve month revenue for Medmix Group is $551M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
